Operating
Operating lease right-of-use asset amortization
ResMed Operating lease right-of-use asset amortization decreased by 6.5% to $9.97M in Q3 2025 compared to the prior quarter. Year-over-year, this metric grew by 11.0%, from $8.98M to $9.97M. Over 3 years (FY 2022 to FY 2025), Operating lease right-of-use asset amortization shows relatively stable performance with a 2.9% CAGR.
Analysis
StatementCash Flow Statement
SectionOperating
CategoryEfficiency
SignalContext dependent
VolatilityStable
First reportedQ1 2020
Last reportedQ1 2026Oct 31, 2025
How to read this metric
Stable levels reflect a consistent lease portfolio, while spikes may indicate changes in lease terms or new major lease agreements.
Detailed definition
This represents the non-cash amortization of the right-of-use asset created under lease accounting standards. It reflect...
Peer comparison
Standard for companies with significant leased real estate footprints.
Metric ID:
operating_operating_lease_right_of_use_asset_amortizatio_94fda1Historical Data
18 periods
| Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $8.96M | $8.52M | $7.02M | $11.10M | $7.60M | $7.76M | $9.33M | $6.87M | $8.44M | $8.51M | $9.94M | $9.82M | $11.08M | $8.98M | $13.44M | $4.26M | $10.66M | $9.97M |
| QoQ Change | — | -4.9% | -17.6% | +58.3% | -31.6% | +2.2% | +20.3% | -26.4% | +22.8% | +0.8% | +16.8% | -1.2% | +12.8% | -18.9% | +49.6% | -68.3% | +150.1% | -6.5% |
| YoY Change | — | — | — | — | -15.2% | -8.9% | +33.0% | -38.1% | +11.1% | +9.6% | +6.5% | +42.9% | +31.3% | +5.5% | +35.2% | -56.6% | -3.8% | +11.0% |
Range$4.26M – $13.44M
CAGR+2.6%
Avg YoY Growth+4.5%
Median YoY Growth+8.0%
Operating lease right-of-use asset amortization at Other Companies
Frequently Asked Questions
- What is ResMed's operating lease right-of-use asset amortization?
- ResMed (RMD) reported operating lease right-of-use asset amortization of $9.97M in Q3 2025.
- How has ResMed's operating lease right-of-use asset amortization changed year-over-year?
- ResMed's operating lease right-of-use asset amortization increased by 11.0% year-over-year, from $8.98M to $9.97M.
- What is the long-term trend for ResMed's operating lease right-of-use asset amortization?
- Over 3 years (2022 to 2025), ResMed's operating lease right-of-use asset amortization has grown at a 2.9% compound annual growth rate (CAGR), from $34.23M to $37.34M.
- What does operating lease right-of-use asset amortization mean?
- The non-cash expense representing the consumption of leased property rights over time.